Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-01-02 @ 9:52 AM
Study NCT ID:
NCT07215832
Status:
AVAILABLE
Last Update Posted:
2025-10-14
First Post:
2025-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Karyopharm Expanded Access Program for Selinexor
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KEAP-KPT-330
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |